Evidence map›Paper›PMID 42226476›Full record

ArticleJournal of cardiovascular electrophysiology2026

Combined Pulsed Field and Radiofrequency Ablation for Coexisting Atrial Tachycardia During or After Atrial Fibrillation Ablation. Interventional and Clinical Outcomes.

Panagiotis Ioannidis, Dimitrios Gerontitis, Vassiliki Tsonona, Panagiotis Charalambopoulos, Dimitra Samara, Alexandros Vassilopoulos, Konstantinos Kouvelas, Evangelia Christoforatou, Dimitrios Katsaras

Abstract read
In one paragraph

Article in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Panagiotis IoannidisHeart Rhythm Center, IASO Hospital, Athens, Greece.ORCID 0000-0002-3529-7882
Dimitrios GerontitisHeart Rhythm Center, IASO Hospital, Athens, Greece.ORCID 0000-0002-2411-5019
Vassiliki TsononaHeart Rhythm Center, IASO Hospital, Athens, Greece.
Panagiotis CharalambopoulosHeart Rhythm Center, IASO Hospital, Athens, Greece.
Dimitra SamaraHeart Rhythm Center, IASO Hospital, Athens, Greece.
Alexandros VassilopoulosHeart Rhythm Center, IASO Hospital, Athens, Greece.
Konstantinos KouvelasHeart Rhythm Center, IASO Hospital, Athens, Greece.
Evangelia ChristoforatouHeart Rhythm Center, IASO Hospital, Athens, Greece.
Dimitrios KatsarasHeart Rhythm Center, IASO Hospital, Athens, Greece.ORCID 0000-0003-3069-1183

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with atrial fibrillation (AF) may develop atrial tachycardias (ATs) post-ablation or intraprocedurally, especially those with persistent AF or fibrotic substrates. Managing these arrhythmias remains challenging in the pulsed field ablation (PFA) era.

methodsThis prospective study included 56 consecutive patients (mean age 71 ± 8.5 years, 42.9% prior AF ablation) with non-paroxysmal AF or AT and history of AF, who exhibited ≥ 1 left-sided AT during ablation. Targeted intervention of the AT mechanism was performed alongside a prespecified prophylactic lesion set (PPLS), comprising pulmonary vein isolation and posterior wall (PW) ablation via the pentaspline PFA catheter, mitral isthmus (MI) ablation using combined radiofrequency ablation (RFA) and PFA, and cavotricuspid isthmus (CTI) ablation with RFA.

resultsA mean of 1.9 ± 0.9 ATs was identified per patient (48.1% macro-reentry, 20.2% localized reentry, 30.8% unmappable). Acute ablation success at all target sites was 100%. Over a mean follow-up of 20.6 ± 6.6 months (minimum 12), sinus rhythm was maintained in 78.6% of patients after the index procedure and 87.5% after repeat. In nine patients undergoing reintervention, durability was 97.2% for pulmonary veins, 89% for MI linear lesions, and 100% for PW and CTI. Pre-ablation clinical AT (35.7% of patients) significantly predicted non-recurrence (p = 0.021). Interestingly, the inability to achieve successful AT mapping (37.5% of patients) did not negatively influence the clinical outcome.

conclusionIn patients with an AF history and left-sided ATs, a PPLS combined with targeted AT mapping and ablation demonstrates excellent outcomes. Integrating RFA and PFA for MI ablation ensures both acute success and high long-term durability.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsPulsed Radiofrequency TreatmentTachycardia, SupraventricularAction PotentialsAgedAged, 80 and overCombined Modality TherapyFemaleHeart RateHumansMaleMiddle AgedProspective StudiesRecurrenceatrial tachycardiashybrid energy sourcemitral isthmus blockpentaspline catheterpost‐atrial fibrillation ablationpulsed field ablation

Identifiers

PMID42226476
PMCPMC13475163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.